Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Biotech
BMS banks on Wall Street vet for strategy— Chutes & Ladders
BMS tapped a Wall Street vet to shape strategy. FDA’s CBER head is adding a new title. Isomorphic Labs tapped a new CMO. And more.
Darren Incorvaia
,
Zoey Becker
Jun 20, 2025 8:30am
BMS taps biotech analyst to lead long-term strategy
Jun 13, 2025 11:11am
BMS expands radiopharma pipeline
Jun 11, 2025 4:31am
Protara gears up for next commercial steps—Chutes & Ladders
Jun 6, 2025 8:30am
Are Lilly, Novartis eyeing the PD-1xVEGF field? Execs weigh in
Jun 4, 2025 1:00pm
Gene editor shelves sole clinical asset, lays off 25% of staff
May 19, 2025 2:28pm
